Конкурс уже в третий раз проводят Фонд «Сколково» и международная биофармацевтическая компания «АстраЗенека». Особенностью состязания этого года стало то, что все этапы, включая двухдневный финал, проходят онлайн 30 июня определятся...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
A company working on creating food for prawns from algae has been awarded five million rubles ($82,000) by the Skolkovo Foundation, making it the first startup working in agriculture to receive a mini-grant from the foundation. The company, Solixant , plans...
Здоровые люди не слишком любят ходить к врачу и заниматься предотвращением болезней, и это плохо не только для них самих, но и национальных систем здравоохранения, бюджеты которых могут быть подорваны такими глобальными тенденциями, как старение населения и...
Crowdfunded scientific project OhmyGut , which allows curious Muscovites to discover what’s really going on inside their bellies, has proved a hit, raising more than twice its target amount of funding over two weeks before its completion deadline. ...